Abiraterone Acetate 00378-6920
Product NDC
00378-6920- Manufacturer
- Mylan Pharmaceuticals Inc.
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- November 21, 2018
- Listing Expires
- December 31, 2027
- Application
- ANDA208446
Need to source Abiraterone Acetate? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Abiraterone Acetate | 250 mg/1 |
Drug Class
Cytochrome P450 17A1 Inhibitor [EPC]Cytochrome P450 17A1 Inhibitors [MoA]Cytochrome P450 2C8 Inhibitors [MoA]
Packaging Options(1)
120 TABLET in 1 BOTTLE, PLASTIC (0378-6920-78)